Open Access

Introduction, recap and overview of evidence for SGLT2 inhibitors in HFrEF.

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Sponsored by Boehringer Ingelheim & Eli Lilly

Congress Presentation

About the speaker

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)
114 presentations

2 more presentations in this session

Implementing an SGLT2i for HFrEF treatment in my practice.

Speaker: Professor A. Stewart Coats (Sydney, AU)


Panel discussion.

Speaker: Professor S. Anker (Berlin, DE)


Access the full session

SGLT2 inhibitors in practice (part 3): the case for early intervention in HFrEF

Speakers: Professor J. Butler, Professor A. Stewart Coats, Professor S. Anker

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb